drugset / Trial / NCT00262028
Study of the Safety and Immune Response of a Meningococcal Vaccine Administered to Healthy Children
RandomizedParallel-groupSingle-blindPrevention
Summary
The purpose of this study is to evaluate the safety and immunogenicity of Novartis (formerly Chiron) Meningococcal ACWY Conjugate Vaccine administered to healthy children ages 1 - 10 years
Timeline
- Start
- 2005-04
- Primary completion
- 2006-11
- Completion
- 2006-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | MenACWY-CRM Vaccine | Vaccine | — | — |
| Comparator | MenACWY-PS Vaccine | Vaccine | — | — |